Wijermans P. Low dose Azanucleosides for high risk (s)MDS and AML. Hematol Meeting Rep [Internet]. 2009 Jun. 16 [cited 2024 Nov. 23];2(15). Available from: https://www.pagepress.org/journals/hmr/article/view/613